Amend Surgical, Inc. is pioneering advancements in adhesive technologies specifically designed for dental and surgical applications. Their flagship product, Amend Tissue Tape, utilizes a bio-inspired adhesive that provides long-lasting protection for oral wounds in challenging environments. This innovative solution addresses the limitations of traditional wound care methods, such as short-acting glues and sutures, by offering a biocompatible hydrogel and chitosan-based glue that adheres effectively to wet and uneven surfaces. Additionally, the company is developing a resorbable barrier that can facilitate the reconnection of peripheral nerves without the need for sutures, showcasing their commitment to enhancing surgical outcomes.

The company is also focused on orthopedic and spinal fusion procedures, offering a unique implant that combines bioactive glass with demineralized allograft bone. This product aims to improve fusion success rates in these complex surgeries. Furthermore, Amend Surgical is exploring future innovations that involve targeted drug delivery systems, which would enhance regenerative outcomes by delivering therapeutics directly to specific sites. Their ongoing research and development efforts are protected by multiple patents, indicating a strong commitment to advancing medical technologies that improve patient care and surgical efficacy.

United States

Amend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFuse, a bone graft substitute and bone void filler.

Amend Surgical, Inc.

Company Details